CD274 and neoplasm: In addition to improved short-term activity, fusion receptor-expressing CAR T cells were also shown to acquire a less differentiated phenotype following stimulation with PD-L1 + tumor cells, which further demonstrates their superior anti-tumor potential since less differentiated T cells are associated with advantages in proliferation and persistence relative to more differentiated T cell subsets [39, 40].